THE ORGANIZATION OF THE BCL6 GENE

被引:0
|
作者
KAWAMATA, N [1 ]
MIKI, T [1 ]
FUKUDA, T [1 ]
HIROSAWA, S [1 ]
AOKI, N [1 ]
机构
[1] TOKYO MED & DENT UNIV,SCH MED,DEPT INTERNAL MED 1,BUNKYO KU,TOKYO 113,JAPAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The chromosomal translocation involving 3q27 has been recently described in B-cell malignancies, especially in diffuse large cell lymphomas. We have previously cloned the breakpoint cluster region of 3q27 designated as the BCL6 locus, pre viously known as BCL5, and subsequently cloned the cDNA for the BCL6 (we previously reported it as BCL5) gene encoding a novel Cys2-His2 zinc-finger protein, which locates adjacent to the breakpoints and is activated through the translocation. To elucidate whether rearrangements occur within the BCL6 gene, we characterized the genomic structure of the gene. The BCL6 gene encompasses about 26 kilobases (kb) and consists of nine exons. Translation start site is located in exon 3 and zinc-finger motif is distributed in the exons 6 to 9. We have identified at least two types of mRNA alternatively spliced, which contain or do not contain exon 2 of 134 bp coding for the 5' untranslated region. A large intron 1 of 9 kb is not efficiently spliced out, which might result in the creation of minor 10-12-kb transcripts observed in the Northern blot analysis in addition to major 3.8-kb transcripts. The breakpoints are clustered around the first exon, and the putative regulatory region of the BCL6 gene is removed through the translocation, leading to the overexpression of the gene.
引用
收藏
页码:1327 / 1330
页数:4
相关论文
共 50 条
  • [21] Primary Bone Lymphoma and BCL6
    Bhagavathi, Sharathkumar
    Fu, Kai
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (01) : 144 - 144
  • [22] BCL6 as a therapeutic target for lymphoma
    Leeman-Neill, Rebecca J.
    Bhagat, Govind
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (02) : 143 - 152
  • [23] A-Miz-ing BCL6
    Wu, XS
    Jelinek, DF
    NATURE IMMUNOLOGY, 2005, 6 (10) : 964 - 966
  • [24] Immunoglobulin (Ig)/BCL6 versus non-Ig/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high-versus low-level expression of BCL6 mRNA
    Ueda, C
    Uchiyama, T
    Ohno, H
    BLOOD, 2002, 99 (07) : 2624 - 2625
  • [25] A-Miz-ing BCL6
    Xiaosheng Wu
    Diane F Jelinek
    Nature Immunology, 2005, 6 : 964 - 966
  • [26] Division of labor for oncogene BCL6
    Dent, Alexander
    BLOOD, 2007, 110 (06) : 1707 - 1708
  • [27] An Expanding Job Description for Bcl6
    Bi, Enguang
    Ye, B. Hilda
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2010, 2 (01) : 5 - 7
  • [28] Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression
    Guo, Ying
    Karube, Kennosuke
    Kawano, Riko
    Suzumiya, Junji
    Takeshita, Morishige
    Kikuchi, Masahiro
    Huang, Gao-Sheng
    Li, Qing
    Ohshima, Koichi
    PATHOLOGY INTERNATIONAL, 2007, 57 (03) : 148 - 152
  • [29] Significance of rearrangement of the BCL6 gene in B-Cell lymphoid neoplasms
    Ohno, H
    Fukuhara, S
    LEUKEMIA & LYMPHOMA, 1997, 27 (1-2) : 53 - 63
  • [30] No evidence for BCL6 gene mutations in peripheral T-cell lymphomas
    Al-Jehani, RM
    Diss, TC
    Du, MQ
    Isaacson, PG
    Dogan, A
    JOURNAL OF PATHOLOGY, 2001, 193 : 18A - 18A